Houston TX 脂肪性肝病临床试验
13项针对 脂肪性肝病的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
招募中3 期
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
招募中3 期
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 以及另外 1 项
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中3 期
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 距离 7 英里
- GSK Investigational Site, Humble · 距离 17 英里
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中3 期
- GSK Investigational Site, Bellaire · 距离 7 英里
- GSK Investigational Site, Humble · 距离 17 英里
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
招募中2 期
- Pioneer Research Solutions, Inc., Houston
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
招募中3 期
- HRI- Medical Center, Houston
- Care Access - Houston, Houston
- Houston Research Institute, Houston
- 以及另外 3 项
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
招募中3 期
- Akero Clinical Study Site, Houston
- Akero Clinical Study Site, Houston
- Akero Clinical Study Site, Houston
- 以及另外 3 项
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
招募中2 期
- Houston Research Institute - Medical Center, Houston
- Houston Research Institute, Houston
- Bellaire Clinical Research, Bellaire · 距离 7 英里
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
招募中3 期
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 距离 7 英里
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
招募中2 期
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
招募中1/2 期欢迎健康志愿者
- Pioneer Research Solutions, Houston
NAFLD Clinical Care Pathway
招募中欢迎健康志愿者
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
招募中观察性研究
- First Surgical Hospital, Bellaire · 距离 7 英里
其他城市的 脂肪性肝病试验
- San Antonio, TX17 项研究
- Miami, FL16 项研究
- New York City, NY16 项研究
- San Diego, CA14 项研究
- Austin, TX13 项研究
- Richmond, VA12 项研究
- Tucson, AZ10 项研究
- Chandler, AZ10 项研究
- Hialeah, FL9 项研究
- Orlando, FL9 项研究
- Dallas, TX9 项研究
- St. Louis, MO9 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）121 项研究
- 转移性癌症104 项研究
- 结直肠癌102 项研究
- 卵巢癌89 项研究
- 急性髓系白血病85 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌68 项研究
- 胰腺癌61 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。